Notably, the study also showed that treatment with pimicotinib provided statistically significant and clinically meaningful improvements in secondary endpoints associated with important patient ...
Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback